BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines cumulative Total Shareholder Return of $100 Investment — NASDAQ Biotech Peer Index (USD) ($)
DEF 14A Proxy Statement Pay vs. Performance (XBRL)
Latest, FY2025
125
Period ended Dec 31, 2025
Change on a year earlier
+34.4%
93 in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cumulative Total Shareholder Return of $100 Investment — NASDAQ Biotech Peer Index (USD) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 125 | +34.4% | DEF 14A FY2025 (XBRL) ↗ |
| FY2024 | Dec 31, 2024 | 93 | -1.1% | DEF 14A FY2024 (XBRL) ↗ |
| FY2023 | Dec 31, 2023 | 94 | +4.4% | DEF 14A FY2023 (XBRL) ↗ |
| FY2022 | Dec 31, 2022 | 90 | -10.0% | DEF 14A FY2022 (XBRL) ↗ |
| FY2021 | Dec 31, 2021 | 100 | – | DEF 14A FY2021 (XBRL) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Cumulative Total Shareholder Return of $100 Investment — NASDAQ Biotech Peer Index (USD) ($), annual FY2021–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/tsr_peer
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.